EJSO
metrics 2024
Unveiling breakthroughs in the fight against cancer.
Introduction
The European Journal of Surgical Oncology (EJSO), published by Elsevier Science Ltd, stands as a leading international journal dedicated to the field of surgical oncology. With an ISSN of 0748-7983 and an E-ISSN of 1532-2157, EJSO has been a key resource for researchers and practitioners since its inception in 1985, covering a wide spectrum of topics in advanced surgical techniques, oncology practices, and multidisciplinary approaches to cancer treatment. The journal boasts impressive rankings, being classified in the Q1 quartile for Medicine (Miscellaneous) and Surgery, and Q2 in Oncology for 2023, reflecting its high impact within the scientific community, with a Scopus ranking of #36/551 in Medicine and Surgery, placing it in the 93rd percentile. Although it does not currently offer Open Access options, EJSO remains committed to advancing the field through reliable research and innovative surgical methodologies. Its ongoing contributions are invaluable for those engaged in the continuous improvement of cancer treatment and management.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
European Urology Oncology
Delivering high-quality, peer-reviewed content for medical excellence.European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.
Annals of Thoracic and Cardiovascular Surgery
Elevating the standards of thoracic and cardiovascular surgery.Annals of Thoracic and Cardiovascular Surgery is a distinguished open-access journal dedicated to the advancing field of thoracic and cardiovascular surgery. Published by Int Acad Publishing Co Ltd since 2011, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of cardiology, surgery, gastroenterology, and pulmonary medicine. With an ISSN of 1341-1098 and E-ISSN of 2186-1005, it offers an extensive collection of peer-reviewed research and innovative surgical techniques. The journal is headquartered in Japan and remarkably spans a history of convergence from 1998 to 2024, reflecting its ongoing commitment to publish cutting-edge studies that shape modern surgical practices. Ranking in the Q2 and Q3 quartiles across multiple categories, including surgery and cardiology, the journal's Scopus ranks—#210 in Surgery and #211 in Cardiology—underscore its influence and relevance in the academic landscape. Our aim is to foster a deeper understanding of surgical methodologies, critical care, and clinical advancements, thereby serving as an indispensable resource for the global surgical community.
Bladder Cancer
Fostering innovation in the realm of urological oncology.Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.
Actas Urologicas Espanolas
Connecting Research and Practice in UrologyActas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.
Breast Cancer
Innovating treatment strategies for better patient outcomes.Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.
International Journal of Surgical Oncology
Innovating techniques for improved patient outcomes.The International Journal of Surgical Oncology, published by HINDAWI LTD, stands as a pivotal resource within the realms of surgical and oncology research, with a commendable impact on the field since its inception. Established as an Open Access journal in 2010, it facilitates the dissemination of high-quality, peer-reviewed research that is accessible to a global audience, ensuring that the latest advancements in surgical techniques and oncology treatments reach researchers, practitioners, and students alike. With its current standings of Q3 in Oncology and Q2 in Surgery, alongside impressive Scopus rankings—150/551 in Medicine _ Surgery and 224/404 in Medicine _ Oncology—the journal is recognized for its influential contributions to these critical medical fields. Covering a wide array of topics from innovative surgical methods to comprehensive cancer care approaches, the journal aims to foster collaboration and knowledge-sharing among professionals seeking to enhance patient outcomes across diverse surgical oncology practices. With continued convergence of research from 2012 to 2024, the journal remains at the forefront of addressing contemporary challenges faced in surgical oncology today.
ANNALS OF SURGICAL ONCOLOGY
Transforming patient outcomes with cutting-edge research.The ANNALS OF SURGICAL ONCOLOGY, published by SPRINGER, stands as a leading journal dedicated to advancing the field of surgical oncology. With an ISSN of 1068-9265 and an E-ISSN of 1534-4681, this esteemed publication features high-quality research from 1994 to 2024, contributing significantly to the scientific dialogue surrounding surgical techniques, treatment innovations, and patient outcomes within the oncology community. The journal has earned a prestigious Q1 ranking in Surgery and a Q2 in Oncology for 2023, reflecting its pivotal role in influencing clinical practices and research in these fields. According to Scopus metrics, it ranks #51 out of 551 in Medicine Surgery and #133 out of 404 in Medicine Oncology, underscoring its academic rigor and impact. Despite being a subscription-based journal, the depth of knowledge disseminated through its pages is invaluable for researchers, professionals, and students aiming to stay at the forefront of surgical oncology advancements.
Asian Journal of Surgery
Advancing surgical knowledge for a healthier tomorrow.Asian Journal of Surgery, published by Elsevier Singapore Pte Ltd, is a premier platform for disseminating cutting-edge research in the domain of surgery. Established in 1988 and serving the surgical community across Asia and beyond, this open-access journal has been dedicated to enhancing healthcare practices since it embraced open access in 2016. With an impressive impact factor reflected in its 2023 category quartile ranking of Q2 in Surgery, as well as its commendable Scopus rank (154/551), the journal underscores its influence and relevance in the field. The scope encompasses a wide range of surgical disciplines, fostering the exchange of knowledge and innovation among researchers, clinicians, and students alike. The journal's accessibility furthers its reach, promoting global collaboration and the advancement of surgical techniques and outcomes.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Elevating the standard of gynecological cancer research.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, published by BMJ PUBLISHING GROUP, is a leading interdisciplinary journal focused on advancing research and clinical practice in the field of gynecological oncology. With an ISSN of 1048-891X and an E-ISSN of 1525-1438, the journal has established itself as a vital resource since its inception in 1991, covering cutting-edge advancements through 2024 and beyond. The journal holds esteemed rankings, including Q1 in Obstetrics and Gynecology and Q2 in Oncology, highlighting its influence and high citation impact within the medical community. Its Scopus rankings underscore its prominence, placing it among the top 13% of journals in Obstetrics and Gynecology and the top 27% in Oncology. Although it does not currently offer Open Access options, the journal provides a platform for researchers, clinicians, and students to share significant findings and developments that shape the future of gynecological cancer research and treatment. The INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER stands as a significant pillar in the ongoing effort to improve patient outcomes and foster innovation in this critical area of healthcare.
Interdisciplinary Neurosurgery-Advanced Techniques and Case Management
Uniting Disciplines for Breakthroughs in NeurosurgeryInterdisciplinary Neurosurgery-Advanced Techniques and Case Management, published by ELSEVIER, is a prominent open-access journal that has been actively contributing to the fields of neurology and surgery since its inception in 2014. Recognized for its commitment to disseminating cutting-edge research and clinical case studies, this journal aims to bridge the gap between theoretical knowledge and practical application in neurosurgery. With its E-ISSN 2214-7519, the journal is positioned to reach a global audience of researchers, professionals, and students, enhancing collaboration and knowledge sharing in the interdisciplinary space. Noteworthy is its 2023 rank of Q4 in Neurology (Clinical) and Q3 in Surgery, illustrating its growing influence and engagement within the academic community, even as it strives to elevate its visibility and impact factor. The journal offers an accessible platform for novel insights and advanced techniques, embodying the modern challenges and innovations in neurosurgical practice and case management. Located in Amsterdam, Netherlands, it operates under far-reaching academic standards while fostering an inclusive environment for diverse perspectives in healthcare advancements.